Bivalent mRNA COVID-19 vaccines – ACIP discusses FDA updates to bivalent mRNA vaccine schedules
April 19, 2023, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) expressed their support for the FDA’s amended emergency use authorizations (EUAs) of the Moderna coronavirus disease 2019 (COVID-19) bivalent mRNA vaccine and Pfizer/BioNTech COVID-19 bivalent mRNA vaccine.
Top